ABC Members Featured Among Faculty for the Masters of Medicine 2026 Conference in Jamaica
ABC Members Featured Among Faculty for the Masters of [...]
AstraZeneca launches direct-to-consumer platform to expand access to medications for US patients, including those living with chronic conditions
AstraZeneca today announces the launch of AstraZeneca Direct, an online [...]
BridgeBio to Present Additional Cardiovascular Outcomes Data from ATTRibute-CM at the HFSA Annual Scientific Meeting 2025
PALO ALTO, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- BridgeBio [...]
For the FITs | Navigating the Integration of AI in Cardiovascular Imaging
As cardiovascular medicine advances into the digital age, artificial intelligence [...]
American Heart Association Backs Auxira Health to Alleviate Cardiologist Burnout
The American Heart Association’s venture arm invested in Auxira Health, [...]
2025 ABC International Dr. Jay Brown Abstract Competition | June 28
The Association of Black Cardiologists (ABC), supported, in part, by Amgen [...]
Amgen Announces Robust Weight Loss With Maritide In People Living With Obesity Or Overweight At 52 Weeks In A Phase 2 Study
MariTide Demonstrated up to ~20% Average Weight Loss at 52 [...]
Attruby™ (acoramidis), a Near Complete TTR Stabilizer (≥90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients
– Attruby is the first and only approved product with a [...]
Open-Label Extension Data Confirms Sustained Benefit of Acoramidis on Cardiovascular Outcomes, Including Statistically Significant Reduction in ACM Within 36 Months
Acoramidis demonstrated the earliest known time to separation in cardiovascular [...]